Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease
Falkevall, Annelie, Mehlem, Annika, Palombo, Isolde, Heller Sahlgren, Benjamin, Ebarasi, Lwaki, He, Liqun, Ytterberg, A. Jimmy, Olauson, Hannes, Axelsson, Jonas, Sundelin, Birgitta, Patrakka, Jaakko, Scotney, Pierre, Nash, Andrew, Eriksson, Ulf
Published in Cell metabolism (07.03.2017)
Published in Cell metabolism (07.03.2017)
Get full text
Journal Article
Loading…
Increased protein expression of VEGF-A, VEGF-B, VEGF-C and their receptors in the temporal neocortex of pharmacoresistant temporal lobe epilepsy patients
Castañeda-Cabral, José Luis, Beas-Zárate, Carlos, Rocha-Arrieta, Luisa L., Orozco-Suárez, Sandra A., Alonso-Vanegas, Mario, Guevara-Guzmán, Rosalinda, Ureña-Guerrero, Mónica E.
Published in Journal of neuroimmunology (15.03.2019)
Published in Journal of neuroimmunology (15.03.2019)
Get full text
Journal Article
Loading…
Loading…
Levels of angiogenesis‐related vascular endothelial growth factor family in neovascular glaucoma eyes
Chen, Shida, Zhou, Minwen, Wang, Wei, Wu, Huimin, Yu, Xiling, Huang, Wenbin, Gao, Xinbo, Wang, Jiawei, Li, Xingyi, Du, Shaolin, Ding, Xiaoyan, Zhang, Xiulan
Published in Acta ophthalmologica (Oxford, England) (01.11.2015)
Published in Acta ophthalmologica (Oxford, England) (01.11.2015)
Get full text
Journal Article
Loading…
Age-Related Macular Degeneration and Diabetic Retinopathy
Year of Publication 2022
Get full text
eBook
Loading…
Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Year of Publication 2021
Get full text
eBook
Loading…
Loading…
Loading…
Loading…
Methods of treating diabetic nephropathy by administering an anti-vegf-b (vascular endothelial growth factor-b) antibody
Year of Publication 01.03.2022
Get full text
Patent
Loading…
Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)
Year of Publication 30.03.2021
Get full text
Patent
Loading…
Loading…
US Patent Issued to CSL, B-CREATIVE SWEDEN on Sept. 10 for "Method of treating diabetic nephropathy in a subject suffering from type 2 diabetes by administering an antibody which inhibits VEGF-B signaling" (Australian, Swedish Inventors)
Published in US Fed News Service, Including US State News
(11.09.2019)
Get full text
Newsletter
Loading…
Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell
Wu, J., Wei, H., Qu, H., Feng, Z., Long, J., Ge, Q., Deng, H.
Published in Journal of endocrinological investigation (01.11.2017)
Published in Journal of endocrinological investigation (01.11.2017)
Get full text
Journal Article
Loading…
Loading…
Method of treating stroke by administering a compound that inhibits VEGF-B signaling in combination with a thrombolytic agent
Year of Publication 02.07.2019
Get full text
Patent